Financial News
Crispr Therapeutics Ag (NQ: CRSP )
Historical Prices
Year:
| Date | Open | High | Low | Close | Volume | Change (%) |
|---|---|---|---|---|---|---|
| Jul 30, 2021 | 122.44 | 125.31 | 119.35 | 121.02 | 1,433,962 | +2.02(+1.70%) |
| Jul 29, 2021 | 120.64 | 122.61 | 117.89 | 119.00 | 1,207,829 | -0.75(-0.63%) |
| Jul 28, 2021 | 117.48 | 121.40 | 116.01 | 119.75 | 854,303 | +2.32(+1.98%) |
| Jul 27, 2021 | 119.27 | 120.80 | 113.34 | 117.43 | 1,103,334 | -1.79(-1.50%) |
| Jul 26, 2021 | 120.96 | 123.61 | 118.51 | 119.22 | 1,056,780 | -3.05(-2.49%) |
| Jul 23, 2021 | 124.50 | 124.64 | 119.39 | 122.27 | 1,048,585 | -2.50(-2.00%) |
| Jul 22, 2021 | 130.07 | 130.46 | 124.30 | 124.77 | 923,075 | -3.68(-2.86%) |
| Jul 21, 2021 | 124.00 | 129.48 | 122.88 | 128.45 | 1,220,356 | +4.31(+3.47%) |
| Jul 20, 2021 | 124.82 | 125.51 | 120.70 | 124.14 | 1,413,321 | -1.59(-1.26%) |
| Jul 19, 2021 | 122.74 | 129.22 | 122.02 | 125.73 | 1,120,196 | -0.52(-0.41%) |
| Jul 16, 2021 | 128.42 | 130.46 | 125.83 | 126.25 | 934,166 | -0.85(-0.67%) |
| Jul 15, 2021 | 129.57 | 130.19 | 123.81 | 127.10 | 1,201,638 | -3.21(-2.46%) |
| Jul 14, 2021 | 136.00 | 136.74 | 129.52 | 130.31 | 1,068,780 | -5.24(-3.87%) |
| Jul 13, 2021 | 140.09 | 141.16 | 135.27 | 135.55 | 997,313 | -5.20(-3.69%) |
| Jul 12, 2021 | 143.40 | 144.73 | 138.24 | 140.75 | 886,782 | -3.58(-2.48%) |
| Jul 09, 2021 | 144.68 | 146.96 | 141.57 | 144.33 | 1,090,629 | -0.48(-0.33%) |
| Jul 08, 2021 | 135.87 | 145.55 | 136.00 | 144.81 | 1,300,534 | +2.52(+1.77%) |
| Jul 07, 2021 | 148.46 | 150.76 | 140.87 | 142.29 | 1,434,932 | -5.81(-3.92%) |
| Jul 06, 2021 | 151.65 | 155.87 | 146.27 | 148.10 | 1,614,701 | -7.78(-4.99%) |
| Jul 02, 2021 | 156.41 | 158.26 | 151.52 | 155.88 | 1,160,600 | -0.76(-0.49%) |
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
